Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,626
Out of 4,901 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $3.53 | -65.99% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $2.28 | +20,952.63% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $750,000 | $0.91 | +82,644,528.10% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $9.38 | +23,887.21% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $43.00 | +388.37% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $3.53
Upside: -65.99%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $2.28
Upside: +20,952.63%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $750,000
Current: $0.91
Upside: +82,644,528.10%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $9.38
Upside: +23,887.21%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $43.00
Upside: +388.37%